https://www.ft.com/content/5730d761-2a7e-470f-8bee-953b64f7775d
Revolution Medicines To Present New Clinical Data At Major Oncology Conferences And Host Investor Webcast
Interim Data to be Presented for RMC-6236 (RASMULTI(ON) Inhibitor) and RMC-6291 (RASG12C(ON) Inhibitor) Company to Host Investor Webcast Following ESMO Data Presentation on October 22 at 12:30 p.m.